Physician profile
Megan E Jacobs
NPI 1891987269
$4,070.68
in general payments reported to CMS, 2019-2025
19 companies · $329 in 2025
The $329 reported for 2025 was more than what 87% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $876 · 2022: $1,383 · 2023: $1,270 · 2024: $213 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,799 · Education: $12.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,799.38 |
| Education | $12.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $915.62 | 2021-2025 | Qelbree, Qelbree |
| Abbvie INC. | $786.41 | 2021-2023 | |
| Corium, LLC | $335.48 | 2021-2025 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $297.52 | 2021-2023 | |
| Neos Therapeutics, LP | $270.48 | 2022-2023 | Adzenys Xr-Odt |
| Otsuka America Pharmaceutical, INC. | $265.98 | 2021-2024 | Rexulti |
| Tris Pharma INC | $230.74 | 2021-2023 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $226.47 | 2022-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $217.90 | 2021-2023 | Trintellix |
| Janssen Pharmaceuticals, INC | $113.63 | 2021-2023 | Spravato |
| Noven Therapeutics, LLC | $77.92 | 2023 | Xelstrym |
| Alkermes, INC. | $76.19 | 2022 | |
| Lundbeck LLC | $75.17 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $41.46 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $40.60 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $34.62 | 2022-2023 | Quviviq |
| Collegium Pharmaceutical, INC. | $27.70 | 2025 | Jornay Pm |
| Axsome Therapeutics, INC. | $22.86 | 2022 | |
| Adlon Therapeutics L.P. | $13.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.